Skip to content

Comparative study of efficacy and safty of Travatanz and Xalatan

Comparative study of efficacy and safty of Travatanz and Xalatan - Comparative study of efficacy and safty of Travatanz and Xalatan

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001874
Enrollment
20
Registered
2009-04-11
Start date
2009-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

xalatan to one eye travatanz to fellow eye

Sponsors

keio university school of medicine department of ophthalmology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Primary open angle glaucma

Exclusion criteria

Exclusion criteria: history of intraocular surgery advanced glaucoma patient

Design outcomes

Primary

MeasureTime frame
Intraocular pressure, hyperemia

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026